Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Revenue of $64.9 million for Q1 2026, up 223.64% year-over-year from $20.0 million in Q1 2025, and down 5.62% quarter-over-quarter from $68.7 million in Q4 2025.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $64.9 million for Q1 2026.
- In Q1 2026, Revenue rose 223.64% year-over-year to $64.9 million; the TTM figure through Mar 2026 stood at $217.4 million (up 397.28% YoY), while the FY2025 annual figure was $172.4 million, up 627.84% from the prior year.
- Revenue for Q1 2026 stood at $64.9 million, down from $68.7 million in the prior quarter.
- The five-year high for Revenue was $68.7 million in Q4 2025, with the low at $3.5 million in Q2 2024.
- The 3-year median for Revenue is $29.0 million (2025), against an average of $32.6 million.
- The sharpest annual moves came in 2025 and 2026: Revenue soared 984.51% in 2025, then soared 223.64% in 2026.
- Syndax Pharmaceuticals' Revenue stood at $7.7 million in 2024, then surged by 794.9% to $68.7 million in 2025, then slipped by 5.62% to $64.9 million in 2026.
- Business Quant data shows SNDX's Revenue at $64.9 million in Q1 2026, $68.7 million in Q4 2025, and $45.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Syndax Pharmaceuticals | 1.85 Bn | 1.30 Bn | 60.67 Mn | 72.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.79 Mn |
| Mar 31, 2026 | 64.86 Mn |
| Dec 31, 2025 | 68.73 Mn |
| Sep 30, 2025 | 45.87 Mn |
| Jun 30, 2025 | 37.96 Mn |
| Mar 31, 2025 | 20.04 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Dec 31, 2021 | 126.58 Mn |
| Sep 30, 2021 | 12.38 Mn |
| Jun 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 379,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Sep 30, 2020 | 379,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Sep 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 379,000.00 |